A little green might not be a cure for the blues. New research suggests medical marijuana isn’t the mental health miracle ...

The largest review of medicinal cannabis to date found it doesn’t effectively treat anxiety, depression, or PTSD—despite ...

Fast-tracked psychedelics hit a wall: why the FDA’s pause on psilocybin is an important check to ensure safety, rigor, and ...

Determination of bioequivalence to the Reference Listed Drug is essential for approval of an Abbreviated New Drug Application ...

The largest systematic review, published in The Lancet Psychiatry, finds medical cannabis does not benefit anxiety, ...

A landmark study finds no evidence that medicinal cannabis is effective for depression, anxiety, or PTSD, warning that ...

A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids ...

Explore NMDA receptor modulation and its critical role in neuronal development and cognitive functions like learning and ...

How brain changes, hormonal shifts, genetics, and environmental factors contribute to postpartum depression and influence ...

AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to ...

A large meta-analysis of 54 randomized controlled trials found no evidence that medicinal cannabis effectively treats anxiety ...